Solventum
American health care company spun off from 3M in 2024
SOLV NYSE
ISIN US83444M1018 SEC CIK 1964738 LEI 254900I70403OSGY4M28
Follow Solventum
Weekly email: filings, results
Revenue, last quarter
$1.9B
−7% vs same quarter last year
Net income
−$12M
−100.9% vs same quarter last year
EPS, diluted
−$0.07
−101% vs same quarter last year
Operating cash flow
$177M
+132.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $8.3B | $1.6B |
| FY24 | $8.3B | $479M |
| FY23 | $8.2B | $1.3B |
| FY22 | $8.1B | $1.3B |
| FY21 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 53.5% | 26.2% | 18.7% |
| FY24 | 55.6% | 12.6% | 5.8% |
| FY23 | 57.3% | 20.6% | 16.4% |
| FY22 | 57.7% | 20.8% | 16.5% |
| FY21 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$10M |
| FY24 | $805M |
| FY23 | $1.6B |
| FY22 | $1.4B |
| FY21 | - |
- Solventum
- Healthcare median
Show the numbers
| Year | Solventum | Healthcare median |
|---|---|---|
| FY25 | 18.7% | −30.6% |
| FY24 | 5.8% | −47% |
| FY23 | 16.4% | −58% |
| FY22 | 16.5% | −80.4% |
| FY21 | - | −71.9% |